167 related articles for article (PubMed ID: 16430776)
41. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma.
Di Saverio S; Gutierrez J; Avisar E
Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874
[TBL] [Abstract][Full Text] [Related]
42. Breast cancer incidence and mortality in the Nordic capitals, 1970-1998. Trends related to mammography screening programmes.
Törnberg S; Kemetli L; Lynge E; Helene Olsen A; Hofvind S; Wang H; Anttila A; Hakama M; Nyström L
Acta Oncol; 2006; 45(5):528-35. PubMed ID: 16864165
[TBL] [Abstract][Full Text] [Related]
43. Early diagnosis, not differential treatment, explains better survival in service screening.
Paci E; Ponti A; Zappa M; Patriarca S; Falini P; Delmastro G; Bianchi S; Sapino A; Vezzosi V; Senore C; Crocetti E; Frigerio A; Zanetti R; Del Turco MR; Segnan N
Eur J Cancer; 2005 Nov; 41(17):2728-34. PubMed ID: 16239106
[TBL] [Abstract][Full Text] [Related]
44. [Clear-cut beneficial effect of breast cancer screening on the trend in breast-conserving surgery].
van der Hage JA; van de Velde CJ
Ned Tijdschr Geneeskd; 2002 Jun; 146(22):1029-31. PubMed ID: 12073504
[TBL] [Abstract][Full Text] [Related]
45. [Diagnostic role of mammography and clinical examination in the framework of a screening program for breast carcinoma in Brescia].
Filippini L; Pinelli D; Bettoni C; Bianchi A; Perna F; Lucini L; Vaiana R; Braga M
Minerva Med; 1996 Nov; 87(11):531-8. PubMed ID: 9045104
[TBL] [Abstract][Full Text] [Related]
46. Nationwide breast cancer screening programme fully implemented in The Netherlands.
Fracheboud J; de Koning HJ; Boer R; Groenewoud JH; Verbeek AL; Broeders MJ; van Ineveld BM; Hendriks JH; de Bruyn AE; Holland R; van der Maas PJ;
Breast; 2001 Feb; 10(1):6-11. PubMed ID: 14965550
[TBL] [Abstract][Full Text] [Related]
47. The characteristics of interval breast cancer in mass screening.
Morimoto T; Komaki K; Oshimo K; Miki H; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Monden Y
Tokushima J Exp Med; 1992 Dec; 39(3-4):109-16. PubMed ID: 1295127
[TBL] [Abstract][Full Text] [Related]
48. Disease-specific survival in patient-detected breast cancer.
Kaplan HG; Malmgren JA
Clin Breast Cancer; 2006 Jun; 7(2):133-40. PubMed ID: 16800972
[TBL] [Abstract][Full Text] [Related]
49. [Management of breast cancer detected by a mammography program in the Ariana area of Tunisia].
Chelli D; Dimassi K; Zaanouni E; Sfar E; Ben Aissa R; Bouchlaka A; Ben Hmida A; Chelli H; Gueddana N; Chennoufi MB
Tunis Med; 2009 Jul; 87(7):471-4. PubMed ID: 20063682
[TBL] [Abstract][Full Text] [Related]
50. [Mass mammography screening. A means of reducing mortality in breast cancer?].
Bauer M; Schulz-Wendtland R; von Fournier D
Radiologe; 1988 Mar; 28(3):95-102. PubMed ID: 3287445
[TBL] [Abstract][Full Text] [Related]
51. Pathology characteristics that optimize outcome prediction of a breast screening trial.
Anderson TJ; Alexander FE; Lamb J; Smith A; Forrest AP
Br J Cancer; 2000 Aug; 83(4):487-92. PubMed ID: 10945496
[TBL] [Abstract][Full Text] [Related]
52. Twenty-year follow-up breast screening project.
Letton AH; Mason EM; Ramshaw B
J Med Assoc Ga; 1996 Jan; 85(1):31-2. PubMed ID: 8583185
[TBL] [Abstract][Full Text] [Related]
53. Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers.
Domingo L; Blanch J; Servitja S; Corominas JM; Murta-Nascimento C; Rueda A; Redondo M; Castells X; Sala M
Eur J Cancer Prev; 2013 Jan; 22(1):21-8. PubMed ID: 22584215
[TBL] [Abstract][Full Text] [Related]
54. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004.
Paajanen H; Kyhälä L; Varjo R; Rantala S
Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250
[TBL] [Abstract][Full Text] [Related]
55. Differences in Breast Cancer Characteristics by Mammography Screening Participation or Non-Participation.
Braun B; Khil L; Tio J; Krause-Bergmann B; Fuhs A; Heidinger O; Hense HW
Dtsch Arztebl Int; 2018 Aug; 115(31-32):520-527. PubMed ID: 30149831
[TBL] [Abstract][Full Text] [Related]
56. Effect of service screening mammography on population mortality from breast carcinoma.
Feig SA
Cancer; 2002 Aug; 95(3):451-7. PubMed ID: 12209736
[No Abstract] [Full Text] [Related]
57. [40 years breast carcinoma treatment in the Neubrandenburg region.Can an increase in prognostically more favorable stages be detected?].
Rühle H; Grobe N; Balschat S; Ernst KF; Dewitz D; Winkler L
Z Arztl Fortbild Qualitatssich; 1997 Mar; 91(2):135-7. PubMed ID: 9244654
[TBL] [Abstract][Full Text] [Related]
58. Survival of cancer patients in Italy in the nineties: the importance of population based data.
Zanetti R; Falcini F; Simonato L; Vercelli M
Epidemiol Prev; 2001; 25(3 Suppl):1-8. PubMed ID: 11695194
[TBL] [Abstract][Full Text] [Related]
59. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
60. Isolating the effect of confounding from the observed survival benefit of screening participants - a methodological approach illustrated by data from the German mammography screening programme.
Buschmann L; Wellmann I; Bonberg N; Wellmann J; Hense HW; Karch A; Minnerup H
BMC Med; 2024 Jan; 22(1):43. PubMed ID: 38287392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
